Radioiodinated folic acid conjugates: Evaluation of a valuable concept to improve tumor-to-background contrast

Molecular Pharmaceutics

Volumn 9, Issue 5, 2012, Pages 1213-1221

  Reber, Josefine ^a   Struthers, Harriet ^b   Betzel, Thomas ^b   Hohn, Alexander ^a   Schibli, Roger ^a,b   Müller, Cristina ^a  

^a ETH Zurich   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

folate receptor; iodine; radionuclide therapy; SPECT CT; tyrosine folate

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FOLIC ACID; FOLIC ACID DERIVATIVE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FOLIC ACID; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TYROSINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860742706     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200511t     Document Type: Article

References (35)

1. Weitman, S. D.; Lark, R. H.; Coney, L. R.; Fort, D. W.; Frasca, V.; Zurawski, V. R.; Kamen, B. A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues Cancer Res. 1992, 52 (12) 3396-3401
2. Antony, A. C. Folate receptors Ann. Rev. Nutr. 1996, 16, 501-521
3. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 2005, 338 (2) 284-293
4. Low, P. S.; Henne, W. A.; Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 2008, 41 (1) 120-9
5. Ke, C. Y.; Mathias, C. J.; Green, M. A. Folate-receptor-targeted radionuclide imaging agents Adv. Drug Delivery Rev. 2004, 56 (8) 1143-1160
6. Sega, E. I.; Low, P. S. Tumor detection using folate receptor-targeted imaging agents Cancer Metastasis Rev. 2008, 27 (4) 655-64
7. Müller, C.; Schibli, R. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer J. Nucl. Med. 2011, 52 (1) 1-4
8. Holm, J.; Hansen, S. I.; Hoiermadsen, M.; Bostad, L. A high-affinity folate binding-protein in proximal tubule cells of human kidney Kidney Int. 1992, 41 (1) 50-55
9. Birn, H.; Spiegelstein, O.; Christensen, E. I.; Finnell, R. H. Renal tubular reabsorption of folate mediated by folate binding protein 1 J. Am. Soc. Nephrol. 2005, 16 (3) 608-615
10. Sandoval, R. M.; Kennedy, M. D.; Low, P. S.; Molitoris, B. A. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy Am. J. Physiol. Cell Physiol. 2004, 287 (2) C517-C526
11. 67Ga-DOTA-Bz-folate-investigations of methods to improve the tissue distribution of radiofolates Nucl. Med. Biol. 2011, 38 (5) 715-23
12. Müller, C.; Brühlmeier, M.; Schubiger, A. P.; Schibli, R. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo J. Nucl. Med. 2006, 47 (12) 2057-2064
13. 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer J. Nucl. Med. 2008, 49 (4) 623-9
14. Müller, C.; Reddy, J. A.; Leamon, C. P.; Schibli, R. Effects of the Antifolates Pemetrexed and CB3717 on the Tissue Distribution of Tc-99m-EC20 in Xenografted and Syngeneic Tumor-Bearing Mice Mol. Pharmaceutics 2010, 7 (2) 597-604
15. Tarli, L.; Balza, E.; Viti, F.; Borsi, L.; Castellani, P.; Berndorff, D.; Dinkelborg, L.; Neri, D.; Zardi, L. A high-affinity human antibody that targets tumoral blood vessels Blood 1999, 94 (1) 192-8
16. 99mTc- labeled human recombinant anti-ED-B fibronectin antibody fragments J. Nucl. Med. 2006, 47 (10) 1707-16
17. Krummeich, C.; Holschbach, M.; Stocklin, G. Direct n.c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice Appl. Radiat. Isot. 1994, 45 (9) 929-35
18. Arlt, M. J.; Novak-Hofer, I.; Gast, D.; Gschwend, V.; Moldenhauer, G.; Grunberg, J.; Honer, M.; Schubiger, P. A.; Altevogt, P.; Kruger, A. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment Cancer Res. 2006, 66 (2) 936-43
19. Ke, C. Y.; Mathias, C. J.; Green, M. A. The folate receptor as a molecular target for tumor-selective radionuclide delivery Nucl. Med. Biol. 2003, 30 (8) 811-817
20. Garin-Chesa, P.; Campbell, I.; Saigo, P. E.; Lewis, J. L.; Old, L. J.; Rettig, W. J. Trophoblast and ovarian cancer antigen LK26-sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein Am. J. Pathol. 1993, 142 (2) 557-567
21. Hattori, Y.; Maitani, Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase Cancer Gene Ther. 2005, 12 (10) 796-809
22. Ladino, C. A.; Chari, R. V. J.; Bourret, L. A.; Kedersha, N. L.; Goldmacher, V. S. Folate-maytansinoids: target-selective drugs of low molecular weight Int. J. Cancer 1997, 73 (6) 859-864
23. Mathias, C. J.; Wang, S.; Lee, R. J.; Waters, D. J.; Low, P. S.; Green, M. A. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate J. Nucl. Med. 1996, 37 (6) 1003-1008
24. 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting Eur J. Nucl. Med. Mol. Imaging 2006, 33 (9) 1007-1016
25. 99mTc-based radiopharmaceutical Bioconjugate Chem. 2002, 13 (6) 1200-1210
26. 99mTc-EC20 for imaging folate receptor-positive tumors J. Nucl. Med. 2004, 45 (5) 857-866
27. 3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue Bioconjugate Chem. 2008, 19 (8) 1689-95
28. 99mTc-radiofolate J. Nucl. Med. 2008, 49 (2) 310-317
29. Müller, C.; Mindt, T. L.; de Jong, M.; Schibli, R. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy Eur. J. Nucl. Med. Mol. Imaging 2009, 36 (6) 938-46
30. 99mTc- radiofolate uptake in tumors and kidneys Nucl. Med. Biol. 2007, 34 (6) 603-8
31. Bischof, M.; Weber, K. J.; Blatter, J.; Wannenmacher, M.; Latz, D. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro Int. J. Radiat. Oncol. Biol. Phys. 2002, 52 (5) 1381-8
32. Bischof, M.; Huber, P.; Stoffregen, C.; Wannenmacher, M.; Weber, K. J. Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases Int. J. Radiat. Oncol. Biol. Phys. 2003, 57 (1) 289-92
33. 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer Clin. Cancer Res. 2003, 9 (16 Pt 1) 5842-52
34. 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours Eur. J. Nucl. Med. Mol. Imaging 2008, 35 (4) 743-8
35. 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (2) 302-11